Sunitinib ADR a marker of efficacy

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1347, 2011-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sunitinib

By Deeks Emma D.   Keating Gillian M.  

Drugs, Vol. 66, Iss. 17, 2006-01 ,pp. : 2255-2266

Adis International

Access to resources Recommend Favorite

Sunitinib has demonstrated efficacy for the treatment of patients with neuroendocrine tumours

By  

Inpharma, Vol. 1, Iss. 1648, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Sunitinib as a second-line therapy for advanced GISTs after failure of imatinib: relationship between efficacy and tumor genotype in Korean patients

By Yoon Dok  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 819-827

Springer Publishing Company

Access to resources Recommend Favorite

Comparing the Efficacy of Sunitinib with Sorafenib in Xenograft Models of Human Hepatocellular Carcinoma: Mechanistic Explanation

By  

Current Cancer Drug Targets, Vol. 11, Iss. 8, 2011-10 ,pp. : 944-953

Bentham Science Publishers

Access to resources Recommend Favorite

Multiple gestation as a marker of reproductive efficacy: learning from assisted reproductive technologies

By Zegers-Hochschild F   Bravo M   Fernández E   Fabres C   Balmaceda JP   Mackenna A  

Reproductive BioMedicine Online, Vol. 8, Iss. 1, 2004-01 ,pp. : 125-129

Reproductive Healthcare Ltd

Access to resources Recommend Favorite